Abstract
Background and Purpose: The utility of upper limit of vulnerability (ULV) testing in patients undergoing defibrillator implantation has been reported. The purpose of this study was to evaluate the difference of outcome between patients with ULV 15 J. Methods: A total of 94 consecutive patients were underwent ICD or CRT-D implantation from February 2009 to December 2010. ULV test has performed in 74 patients, which were retrospectively reviewed. At implantation, we delivered 15 J shock on the peak of T-wave three times to ensure that the most vulnerable part of the cardiac cycle is scanned. If VF was not induced, it meant ULV 15 J (n=14) and we delivered 20 J shock subsequently. When defibrillation was failed, defibrillation threshold was examined closely as much as possible. Results: Patient characteristics between two groups were comparable. After mean follow-up of 393±196 days, the proportion of appropriate shocks in the two groups was 0% vs 21% (p=0.003). There was no case of failed appropriate shocks and death in both groups. Conclusion: ULV can be applied to a safety-margin strategy without inducing VF, and also, is the predictor of the occurrence of appropriate shock in patients with ICD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.